The global Recombinant Erythropoietin Market is estimated to be valued at US$ 7.01 billion in 2023 and is expected to exhibit a CAGR of 2% over the forecast period of 2023-2030, according to a new report published by Coherent Market Insights.

Market Overview:
Recombinant erythropoietin (rEPO) is a synthetic form of the hormone erythropoietin, which stimulates the production of red blood cells in the body. It is mainly used ... Read more

Recombinant erythropoietin are artificial forms of erythropoietin produced through recombinant DNA technology. They are commonly used to treat anemia associated with chronic kidney disease and chemotherapy. These drugs stimulate the bone marrow to produce more red blood cells, helping reduce the need for blood transfusions. The recombinant erythropoietins market has grown in importance owing to the development of new compounds which have a longer half-life and require less frequent dosing. ... Read more